Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Porazinski

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|October 5, 2020
WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1Tareg Belali, Chigeru Wodi, Bethany Clark, et al.
Current Biology : CB|April 23, 2021
EPHA2-dependent outcompetition of KRASG12D mutant cells by wild-type neighbors in the adult pancreasWilliam Hill, Andreas Zaragkoulias, Beatriz Salvador-Barbero, et al.
Oncogene|August 17, 2021
TLR2 activation promotes tumour growth and associates with patient survival and chemotherapy response in pancreatic ductal adenocarcinomaJoanne Lundy, Linden J Gearing, Hugh Gao, et al.
British Journal of Cancer|June 26, 2020
Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancerLing Li, Lisa Hobson, Laura Perry, et al.
Frontiers in Oncology|December 16, 2021
Oral Squamous Cell Carcinoma in Young Patients Show Higher Rates of <i>EGFR</i> Amplification: Implications for Novel Personalized TherapyLaveniya Satgunaseelan, Sean Porazinski, Dario Strbenac, et al.
Nature Chemical Biology|April 16, 2021
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1Thomas Kryza, Tashbib Khan, Scott Lovell, et al.
Nature|March 18, 2015
YAP is essential for tissue tension to ensure vertebrate 3D body shapeSean Porazinski, Huijia Wang, Yoichi Asaoka, et al.
Molecular Cancer Therapeutics|July 7, 2025
Integration of whole genome sequencing analysis with unique patient-derived models reveals clinically relevant drug targets in TFCP2 fusion-defined rhabdomyosarcomaPatrick Bergsma, Sean Porazinski, Aji Istadi, et al.
Science Advances|July 3, 2024
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy responseBrooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|October 5, 2020
WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1Tareg Belali, Chigeru Wodi, Bethany Clark, et al.
Current Biology : CB|April 23, 2021
EPHA2-dependent outcompetition of KRASG12D mutant cells by wild-type neighbors in the adult pancreasWilliam Hill, Andreas Zaragkoulias, Beatriz Salvador-Barbero, et al.
Oncogene|August 17, 2021
TLR2 activation promotes tumour growth and associates with patient survival and chemotherapy response in pancreatic ductal adenocarcinomaJoanne Lundy, Linden J Gearing, Hugh Gao, et al.
British Journal of Cancer|June 26, 2020
Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancerLing Li, Lisa Hobson, Laura Perry, et al.
Frontiers in Oncology|December 16, 2021
Oral Squamous Cell Carcinoma in Young Patients Show Higher Rates of <i>EGFR</i> Amplification: Implications for Novel Personalized TherapyLaveniya Satgunaseelan, Sean Porazinski, Dario Strbenac, et al.
Nature Chemical Biology|April 16, 2021
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1Thomas Kryza, Tashbib Khan, Scott Lovell, et al.
Nature|March 18, 2015
YAP is essential for tissue tension to ensure vertebrate 3D body shapeSean Porazinski, Huijia Wang, Yoichi Asaoka, et al.
Molecular Cancer Therapeutics|July 7, 2025
Integration of whole genome sequencing analysis with unique patient-derived models reveals clinically relevant drug targets in TFCP2 fusion-defined rhabdomyosarcomaPatrick Bergsma, Sean Porazinski, Aji Istadi, et al.
Science Advances|July 3, 2024
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy responseBrooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.
Pageof 2